【ChiCTR2300068935】Brief Cognitive Behavioural Therapy Mobile Apps for Young Adults in Balinese rural area
ChiCTR2300068935
尚未开始
/
/
/
2023-03-01
/
/
Mental health
Brief Cognitive Behavioural Therapy Mobile Apps for Young Adults in Balinese rural area
A Development and Implementation of a Brief Cognitive Behavioural Therapy (B-CBT) Based on Mobile Apps (Bali Sujati) in Overcoming Anxiety in Young Adults in Bali Rural Areas: Mixed Methods Study’s Protocol
81116
This study aims at finding out the potential of the MB-CBT implementation in real-world settings. In the long term this interventional study aimed to investigate the impact of the MB-CBT, while measuring well-being and perceived social support in young adults in Balinese rural areas. The secondary objectives are to evaluate the effectiveness of the MB-CBT in reducing participant-reported anxiety and stress.
随机抽样
Ⅰ期
Participants will be randomized by the built-in algorithm in the mobile app with 1:1 ratio to the intervention and control groups. The algorithm is designed for permuted block randomization where the total number of participants is set prior to the randomization.
/
DIPA Direktorat Riset, Teknologi, dan Pengabdian kepada Masyarakat, Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi (Ministry of Education, Culture, Research and Technologies in Indonesia) un
/
194;190
/
2023-03-01
2023-12-27
/
The inclusion criteria are indicate good general health, and no recent adverse life events, have access with smartphone and internet use, and have experienced mild anxiety symptoms as assessed via an initial screening tool with GAD-7 score no more than 14 through survey monkey.;
请登录查看The exclusion criteria for participation in this study are having hard hearing, sight and speech problems, having a serious mental disorder, the GAD-7 score more than 14, and refusing to fill in the informed consent form;
请登录查看Universitas Pendidikan Ganesha, Indonesia
81116
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-14
-
2026-08-14
-
2026-08-14
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-14
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
